Percutaneous coronary intervention in patients with documented coronary vasospasm during long-term follow-up.
Ju Hyeon KimJinoh ParkYujin YangSahmin LeeDae Hee KimJong-Min SongDuk Hyun KangSeong-Wook ParkSeung-Jung ParkJae-Kwan SongPublished in: Heart (British Cardiac Society) (2022)
CAS is a risk factor for the development of FS requiring PCI during long-term follow-up, and warrants physicians' vigilance and careful follow-up of patients with documented CAS and insignificant stenosis of major epicardial coronary arteries at the time of initial diagnosis.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- crispr cas
- genome editing
- st segment elevation myocardial infarction
- coronary artery
- coronary artery bypass grafting
- acute myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- acute coronary syndrome
- primary care
- subarachnoid hemorrhage
- aortic stenosis
- atrial fibrillation
- coronary artery bypass
- heart failure
- transcatheter aortic valve replacement
- blood brain barrier